2 ms·
I think part of it is the industry at large has a speculative and probabilistic nature to development. Much of it is betting on yet to be developed science, so
by s1artibartfast 5y ago
I think part of it is the industry at large has a speculative and probabilistic nature to development. Much of it is betting on yet to be developed science, so so you rarely have a prototype that can be tested and infected. This is certainly the case for devices and drugs. When you couple this lack of objective performance data with an opaque and extremely entrenched Market sector, there's a lot of room for shady business.
To top it off, when Healthcare start up over-promise and under-deliver it gets a level of criticism and outrage that is higher then many other sectors